MTF | Jotup

Grand City Properties S.A. launches an exchange offer with 15% tender option to the holders of certain perpetual notes

Retrieved on:

onsdag, april 10, 2024

MTF, EUR, Exchange, City, S&P, MAR, Grand City Properties, Luxembourg Stock Exchange, Security (finance)

Luxembourg, 2 April 2024 - The Board of Directors of Grand City Properties S.A. (the "Company" and together with its subsidiaries “Grand City Properties”) has resolved today to launch a voluntary exchange and tender offer (the “Offer”) to the holders of two of its Euro dominated outstanding perpetual notes with the ISIN codes XS1491364953 and XS1811181566 (the "Existing Perpetual Notes").

Key Points:

Luxembourg, 2 April 2024 - The Board of Directors of Grand City Properties S.A. (the "Company" and together with its subsidiaries “Grand City Properties”) has resolved today to launch a voluntary exchange and tender offer (the “Offer”) to the holders of two of its Euro dominated outstanding perpetual notes with the ISIN codes XS1491364953 and XS1811181566 (the "Existing Perpetual Notes").
Under the Offer, holders of the Existing Perpetual Notes will have the opportunity to exchange existing eligible holdings into either: (i) new perpetual notes at the relevant exchange ratio and a cash amount for participating in the exchange, or (ii) new perpetual notes at the relevant exchange ratio, a cash amount for participating in the exchange and a 15% redemption of their exchanged notes for cash.
The new undated subordinated notes will be issued by a subsidiary of the Company, Grand City Properties Finance S.à r.l.
Grand City Properties aims to recover the equity content under S&P rating methodology for the perpetual notes which have previously not been called on their respective first call dates.

Aroundtown SA launches exchange offer with 15% tender option to the holders of certain perpetual notes

Retrieved on:

onsdag, april 10, 2024

MTF, Exchange, S&P, MAR, Luxembourg Stock Exchange, Security (finance)

Luxembourg, 2 April 2024 - The Board of Directors of Aroundtown SA (the "Company" and together with its subsidiaries “Aroundtown”) has resolved today to launch a voluntary exchange and tender offer (the “Offer”) to the holders of four of its Euro denominated outstanding perpetual notes with the ISIN codes XS1508392625, XS2055106210, XS1752984440 and XS2027946610 ("Existing Perpetuals Notes").

Key Points:

Luxembourg, 2 April 2024 - The Board of Directors of Aroundtown SA (the "Company" and together with its subsidiaries “Aroundtown”) has resolved today to launch a voluntary exchange and tender offer (the “Offer”) to the holders of four of its Euro denominated outstanding perpetual notes with the ISIN codes XS1508392625, XS2055106210, XS1752984440 and XS2027946610 ("Existing Perpetuals Notes").
Under the Offer, holders of the Existing Perpetual Notes will have the opportunity to exchange existing eligible holdings into either: (i) new perpetual notes at the relevant exchange ratio and a cash amount for participating in the exchange, or (ii) new perpetual notes at the relevant exchange ratio, a cash amount for participating in the exchange and a 15% redemption of their exchanged notes for cash.
Under the Offer, holders of the Existing Perpetual Notes with the ISIN code XS1508392625 and a current coupon of 7.078% and the ISIN code XS2055106210 and a current coupon of 3.375% (coupon of ca.
The details of the Offer will be made available in an Exchange and Tender Offer Memorandum.

General Fusion Partners with Canadian Nuclear Laboratories to Advance Commercial Power Plant Design

Retrieved on:

torsdag, april 4, 2024

Electricity, Tritium, MTF, Nuclear, Face, Research, General Fusion, Private sector, CNRI, CNL, Magnetized target fusion, Lithium

RICHMOND, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- General Fusion has launched a new project in collaboration with Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, to advance the design of its commercial fusion power plant.

Key Points:

RICHMOND, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- General Fusion has launched a new project in collaboration with Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, to advance the design of its commercial fusion power plant.
Now, General Fusion will leverage CNL’s expertise, capabilities, and advanced facilities in power plant design, licensing, and operations.
As a result, General Fusion will refine its design for a practical and economical power plant that is cost competitive.
“Canada has a strong fusion ecosystem, with General Fusion leading the private sector and Canadian Nuclear Laboratories providing world-class fusion R&D,” said Greg Twinney, CEO, General Fusion.

Tradeweb Reports March 2024 Total Trading Volume of $36.2 Trillion and Average Daily Volume of $1.81 Trillion

Retrieved on:

torsdag, april 4, 2024

Professional Services, Technology, Data Analytics, Finance, Software, Banking, MTF, TBA, EUR, RFM, Growth, ETF, RFQ, Credit, Federal, Yoy, ADV

European government bond volumes continued to be strong in March, with strong growth in average daily trading volume in the institutional EUR and UK Gilts businesses.

Key Points:

European government bond volumes continued to be strong in March, with strong growth in average daily trading volume in the institutional EUR and UK Gilts businesses.
Primary market issuance remained robust across Europe and the UK, which generated heavy trading activity from all client types using a wide range of trading protocols.
Strong U.S. credit volumes were driven by increased client adoption of Tradeweb protocols, most notably in request-for-quote (RFQ), portfolio trading and Tradeweb AllTrade®.
Record European credit volumes were supported by continued growth in client use of Tradeweb Automated Intelligent Execution (AiEX) and portfolio trading.

Dr. Mia Talmor Joins the MTF Biologics Board of Directors

Retrieved on:

onsdag, mars 27, 2024

MTF Biologics , a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, has announced the appointment of Mia Talmor, MD , to the MTF Biologics Board of Directors.

Key Points:

MTF Biologics , a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, has announced the appointment of Mia Talmor, MD , to the MTF Biologics Board of Directors.
View the full release here: https://www.businesswire.com/news/home/20240327225210/en/
Dr. Mia Talmor, Professor of Clinical Surgery at The Weill Cornell Medical School and attending surgeon at New York Presbyterian Hospital, has joined the MTF Biologics Board of Directors.
(Photo: Business Wire)
“We are honored to welcome Dr. Talmor to the MTF Board,” said William W. Tomford, MD, Chairman of the MTF Biologics Board of Directors.
Talmor brings a legacy of groundbreaking achievements in plastic surgery,” said Joe Yaccarino, MTF Biologics’ President and CEO.

Tradeweb Reports February 2024 Total Trading Volume of $37.9 Trillion and Average Daily Volume of $1.87 Trillion

Retrieved on:

tisdag, mars 5, 2024

Professional Services, Technology, Data Analytics, Finance, Software, Banking, ADV, Growth, RFM, Government, ETF, Yoy, MTF, RFQ, Federal, Treasury, Credit, Cryptocurrency

Average daily volume (ADV) for the month was $1.87tn, an increase of 31.1 percent (%) year-over-year (YoY).

Key Points:

Average daily volume (ADV) for the month was $1.87tn, an increase of 31.1 percent (%) year-over-year (YoY).
Increased adoption across a wide range of trading protocols, along with sustained rates market volatility, contributed to the increase in volume.
Strong U.S. credit volumes were driven by increased client adoption of Tradeweb protocols, most notably in request-for-quote (RFQ), portfolio trading and Tradeweb AllTrade®.
Strong European credit volumes were supported by continued growth in client use of Tradeweb Automated Intelligent Execution (AiEX) and portfolio trading.

ART SHARE 002 S.A, the sole holder of the iconic artwork from Francis Bacon 'Three Studies for Portrait of George Dyer, 1963' launches the initial offering of its Class B Shares at a price in EUR equivalent of USD 100 per Class B Share.

Retrieved on:

fredag, februari 16, 2024

Estate, USD, Class, Work of art, Calendar, Business, MTF, Photography, Museum, Triptych, Offering, Maker, DACS, Security (finance)

The Offering consists of a minimum of 412,500 Class B Shares corresponding to 75% of all Class B Shares, and a maximum of up to 550,000 Class B Shares, at a fixed price in EUR equivalent to USD 100 per Class B Share.

Key Points:

The Offering consists of a minimum of 412,500 Class B Shares corresponding to 75% of all Class B Shares, and a maximum of up to 550,000 Class B Shares, at a fixed price in EUR equivalent to USD 100 per Class B Share.
The Class B Shares will be offered at an aggregate valuation in EUR equivalent of USD 55 million.
Closing of the Offering and the fixing of the EUR price per Class B Share is expected to take place on 29 February 2024.
Trading of the Class B Shares on the ARTEX Stock Exchange is expected to start on 8 March 2024.

EQS-News: CropEnergies submits delisting application to Frankfurt Stock Exchange

Retrieved on:

tisdag, februari 6, 2024

Internet, Supervisory board, MTF, Federal republic, Federal Financial Supervisory Authority, Documentation, Acquisition, AG, EUR, OTF, Frankfurt Stock Exchange, Cryptocurrency

Therefore, CropEnergies applied for the revocation of the admission of all CropEnergies shares to trading on the regulated market (Prime Standard) of the Frankfurt Stock Exchange on 5 February 2024.

Key Points:

Therefore, CropEnergies applied for the revocation of the admission of all CropEnergies shares to trading on the regulated market (Prime Standard) of the Frankfurt Stock Exchange on 5 February 2024.
CropEnergies shareholders can still accept Südzucker's public delisting tender offer at EUR 11.50 cash per share until 16 February 2024, at midnight (CET).
The delisting of the CropEnergies shares from the regulated market is expected to become effective after the expiry of the acceptance period of the public delisting tender offer by the end of February 2024.
Following the delisting, trading of the CropEnergies share on the regulated market will terminate, which may result in very limited liquidity and price availability of CropEnergies shares.

Tradeweb Reports January 2024 Total Trading Volume of $42.6 Trillion and Record Average Daily Volume of $2.00 Trillion

Retrieved on:

måndag, februari 5, 2024

Technology, Electronic Commerce, Professional Services, Finance, Federal, MTF, Growth, ETF, ADV, Credit, RFM, Yoy, TBA, RFQ, Security (finance)

Average daily volume (ADV) for the month was a record $2.00tn, an increase of 74.6 percent (%) year-over-year (YoY).

Key Points:

Average daily volume (ADV) for the month was a record $2.00tn, an increase of 74.6 percent (%) year-over-year (YoY).
Higher interest rates continued to drive trading in the retail market on the short-end of the curve.
To-Be-Announced (TBA) platform volumes were supported by elevated roll trading activity as well as strong participation from the hedge fund community.
Strong U.S. credit volumes were driven by increased client adoption of Tradeweb protocols, most notably in request-for-quote (RFQ), portfolio trading and Tradeweb AllTrade®.

MTF Biologics Awards 2023 Grants for Innovation in Allograft Translational Research

Retrieved on:

måndag, januari 22, 2024

“MTF Biologics is proud of our long-standing commitment to supporting the scientific and patient communities through our allograft innovation grants,” said Joe Yaccarino, President and CEO of MTF Biologics.

Key Points:

“MTF Biologics is proud of our long-standing commitment to supporting the scientific and patient communities through our allograft innovation grants,” said Joe Yaccarino, President and CEO of MTF Biologics.
“These grants advance the science of allograft tissue transportation and support MTF Biologics’ dedication to saving and healing lives.
We congratulate all of this year's recipients and look forward to the results of their crucial work which will positively impact lives around the world.”
Innovation in Allograft Translational Research Grants fund translational and clinical research in the fields of allograft transplantation and allograft science.
Hans Burchardt Impact Awardee” for the awarded grant with the highest potential clinical impact.”
Letters of Intent are now being accepted for the 2024 MTF Biologics Innovation in Allograft Translational Research Grants Program.